The LUVEN screening test method created by scientist of our company detects cancer at its early stages with the accuracy of up to 96% only comparable to biopsy. None of the existing diagnostic techniques has such a high diagnostic accuracy. The LUVEN technology allows diagnosing the disease at its early stages , thus, giving a chance to thousands of people to prevent its further development.

4.3
See rating distribution
ICO rating reflects the amount of information available about a project and does not indicate its quality. Therefore, ICO rating must not be taken as investment advice

Closed 8 months, 3 weeks ago

Pre-Sale 12/12/2017 noon - 12/29/2017 midnight
Token Sale 01/15/2018 noon - 02/28/2018 midnight
Country Ukraine
L
Lina Lisitsa
SMO/SMM MANAGER
A
Alexander Danilchenko
CEO
N
Nikolay Shchukin
POSTGRADUATE STUDENT OF CHAIR FOR BIOMEDICAL ENGINEERING
A
Aleksander Shchukin
NUCLEAR PHYSICIAN
G
Galina Shchukina
GENETICIST & CYTOLOGIST
G
Grigory Evglevskiy
CTO
A
Alexander Kamensky
PRINCIPAL SOFTWARE ENGINEER
Y
Yana Ivchenko
PR MANAGER
4.3
See rating distribution
ICO rating reflects the amount of information available about a project and does not indicate its quality. Therefore, ICO rating must not be taken as investment advice

Closed 8 months, 3 weeks ago

Pre-Sale 12/12/2017 noon - 12/29/2017 midnight
Token Sale 01/15/2018 noon - 02/28/2018 midnight
Country Ukraine

Financial information

Platform Ethereum
Total raised 26,350 USD

Interest

Alexa rank 13,756,498 th
Telegram participants 1,217
Twitter followers 2,501
Promotional video views 1,102
Similar icos
Disclaimer

TrackICO does not encourage investing in any ICOs published on the platform. Make sure to do your own thorough research before putting money into Initial Coin Offerings. All content on TrackICO is meant to be used for information purposes only, and should not be taken as financial or investment advice.